4833M 15/500
Generic Name: metformin/pioglitazone
Pill imprint 4833M 15/500 has been identified as Actoplus met 500 mg / 15 mg.
ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy.
ActoPlus Met 500 mg / 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Actoplus met Images
- Generic Name:
- metformin/pioglitazone
- Imprint:
-
4833M
15/500 - Strength:
- 500 mg / 15 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Takeda Pharmaceuticals America, Inc.
Advertisement
More Actoplus Met resources
- Actoplus Met
- Actoplus Met (Wolters Kluwer)
- Actoplus Met (Cerner Multum)
- Actoplus Met (Micromedex) - Includes Dosage Information
- Actoplus Met (FDA)
Search Again
